Core Viewpoint - Lijun Pharmaceutical (01513) announced a strategic transaction involving the capital increase and equity transfer agreement with its controlling shareholder, Health元, and a subsidiary, 毛孩子, aimed at optimizing asset structure and focusing on core pharmaceutical business [1] Group 1: Transaction Details - The agreement stipulates that 心有毛孩 will increase its capital contribution to 毛孩子 by RMB 15 million, while Health元 will transfer its 49% equity stake in 毛孩子 to 心有毛孩 [1] - Following the transaction, 心有毛孩 will hold 52.56% of 毛孩子, while Lijun Pharmaceutical's stake will be diluted from 51.00% to 47.44%, and Health元 will no longer hold any equity in 毛孩子 [1] Group 2: Strategic Focus - The transaction aligns with the company's strategy to concentrate on pharmaceutical research, production, and sales, while recognizing the growth potential in the pet medicine industry [1] - Post-transaction, the company plans to allocate more resources and focus on technological innovation and market expansion within the pharmaceutical sector, thereby enhancing profitability and aligning with long-term development strategies [1]

Core Viewpoint - The company, LIZHU PHARMACEUTICAL (01513.HK), has announced a strategic transaction involving capital increase and equity transfer agreements with Health元 and two other entities, focusing on optimizing its asset structure and enhancing governance efficiency [1] Group 1: Transaction Details - The agreement stipulates that "心有毛孩" will increase its capital contribution to "毛孩子" by RMB 15 million, while Health元 will transfer its 49% equity stake in "毛孩子" to "心有毛孩" [1] - Following the completion of this transaction, "心有毛孩" will hold 52.56% of "毛孩子," while the company's stake will be diluted from 51.00% to 47.44%, and Health元 will no longer hold any equity in "毛孩子" [1] Group 2: Strategic Focus - The company is strategically focusing on pharmaceutical research, production, and sales, while recognizing the growth potential in the pet medicine industry represented by "毛孩子" [1] - This transaction is seen as a significant step for the company to concentrate resources on its core business, allowing for sustained sharing of "毛孩子's" long-term growth potential [1] Group 3: Future Implications - Post-transaction, the company plans to allocate more energy and resources towards technological innovation and market expansion within the pharmaceutical sector, aiming to further solidify and enhance its profitability [1] - This move aligns with the company's long-term development strategy and the overall interests of all shareholders [1]

Core Viewpoint - Hainan Airport Facilities Co., Ltd. has approved the transfer of 90% equity in Sanya Airport Infrastructure Co., Ltd. for RMB 499.89 million, aiming to optimize asset structure and focus on core airport operations [7][11][26]. Group 1: Meeting Details - The 37th meeting of the 10th Board of Directors was held on December 25, 2025, with all 9 members present, confirming the legality and validity of the meeting [1]. - The board unanimously approved the proposal for the equity transfer of Sanya Airport Infrastructure Co., Ltd. [2][3]. Group 2: Transaction Overview - The full subsidiary, Hainan Island Airport Development Co., Ltd., will transfer 90% of its shares in Sanya Airport for RMB 499.89 million, retaining a 10% stake post-transaction [7][11]. - The transaction does not constitute a related party transaction or a major asset restructuring [8][12]. Group 3: Financial Assessment - The asset evaluation report indicated that the book value of Sanya Airport's equity was RMB 31.04 million, with an assessed value of RMB 55.54 million, resulting in an appreciation of RMB 24.50 million, or 78.91% [11][18]. - The agreed transfer price of RMB 499.89 million was reached after negotiations between the parties [18][19]. Group 4: Impact of the Transaction - The transaction is expected to enhance the company's asset quality and operational efficiency, with an anticipated investment return of approximately RMB 200 million [26]. - Post-transaction, Sanya Airport will no longer be included in the company's consolidated financial statements, and there will be no management changes or related party transactions [26][27].

Core Viewpoint - Hainan Airport (600515.SH) is divesting 90% of its stake in Sanya Airport Infrastructure Co., Ltd. for approximately 500 million yuan to focus on its core airport operations and optimize its asset structure [1] Group 1 - The company aims to further concentrate on its main business by transferring the majority stake in Sanya Airport Infrastructure [1] - After the completion of the share transfer, the company will retain a 10% stake in Sanya Airport Infrastructure, which will no longer be included in the company's consolidated financial statements [1]

证券日报网讯12月17日，力合科创（002243）在互动平台回答投资者提问时表示，公司本次拟转让八六 三部分股权，是基于整体发展战略规划，旨在优化资产结构并聚焦主业发展，以提升公司竞争力和经营 效益。 ...

格隆汇12月17日丨奥瑞金(002701.SZ)公布，根据公司海外业务发展规划，为优化公司资产结构，提高 资产运营效率，促进公司高质量发展，公司与 Rexam Limited 于 2025 年8 月26 日签署股权买卖协议， 公司下属控股子公司 Benepack Hong Kong Limited（简称"贝纳香港"）拟向 Rexam Limited 出售其持有 的控股子公司 Benepack Belgium N.V.（简称"贝纳比利时"、"标的公司"）80%股权。标的公司整体企业 价值为 1.38 亿欧元，对应 80%股权的基础对价为1.104 亿欧元，最终交易对价将根据交割日报表的现 金、负债及营运资金等指标进行相应调整，预计调整后交易金额约为 5,000 万欧元至 6,000 万欧元。公 司将根据本次交易的进展情况及时履行信息披露义务。 本次交易股权转让前，贝纳比利时股权结构为：贝纳香港持股99.80%，Paulian Investment Holding Limited 与 Haoneng (HK) Limited 各持股0.1%。根据本次交易协议约定，贝纳香港需在本次交易实施前 取得Paulian I ...

本次交易股权转让前，贝纳比利时股权结构为：贝纳香港持股99.80%，Paulian Investment Holding Limited 与 Haoneng (HK) Limited 各持股0.1%。根据本次交易协议约定，贝纳香港需在本次交易实施前 取得Paulian InvestmentHolding Limited 与 Haoneng (HK) Limited 持有的贝纳比利时剩余股权（合计 0.2%），从而取得贝纳比利时 100%股权；本次交易股权转让后，Rexam Limited持股 80%股权，贝纳香 港持股 20%股权，贝纳比利时将不再纳入公司合并报表范围。 格隆汇12月17日丨奥瑞金(002701.SZ)公布，根据公司海外业务发展规划，为优化公司资产结构，提高 资产运营效率，促进公司高质量发展，公司与 Rexam Limited 于 2025 年8 月26 日签署股权买卖协议， 公司下属控股子公司 Benepack Hong Kong Limited（简称"贝纳香港"）拟向 Rexam Limited 出售其持有 的控股子公司 Benepack Belgium N.V.（简称"贝纳比利时"、"标 ...

格隆汇12月15日丨睿创微纳(688002.SH)公布，根据公司整体发展战略和经营计划，为进一步聚焦主航 道，减少亏损业务单元，优化公司资产结构，将资源分配在盈利质量更高、经营风险相对较低的其他业 务，提升资金周转及使用效率，睿创微纳全资子公司为奇投资拟将其持有的睿瓷新材51%股权作价人民 币1707.48万元出售给烟台奇创，其持有的睿瓷新材14%股权作价人民币468.72万元出售给张巨先。本次 股权出售完成后，公司全资子公司为奇投资不再持有睿瓷新材的股权，睿瓷新材将不再纳入公司合并报 表范围。 ...

Core Viewpoint - The company Zhongheng Electric (002364.SZ) plans to divest its entire stake of 7.3346% in the associate company Ningde Zhixiang to focus on its main business and optimize its asset structure [1] Group 1 - The company aims to enhance decision-making efficiency and seize trading opportunities by authorizing its management to handle the transaction, provided the transaction amount is no less than 200 million RMB [1] - The authorized scope includes but is not limited to formulating and adjusting the transaction plan, signing relevant agreements, and handling asset transfer matters [1]

公告称，公司拟通过本次股权处置，优化资产结构及整合资源配置，进一步聚焦公司主业，促进公司长 远发展。 智通财经APP讯，中恒电气(002364.SZ)公告，公司拟通过市场寻找、原股东或标的公司股份回购等方 式，处置持有的参股公司福建宁德智享无限科技有限公司(简称"宁德智享")的全部股权(7.3346%)，并由 公司董事会授权管理层在交易金额不低于2亿元人民币的情况下全权处理本次交易相关事宜。 ...